An integrin centered complex coordinates ion transport and pH to regulate f-actin organization and cell migration in breast cancer

Author:

Capitani ChiaraORCID,Iorio Jessica,Lastraioli Elena,Duranti Claudia,Bagni Giacomo,Altadonna Ginevra ChioccioliORCID,Colasurdo Rossella,Scarpellino Giorgia,Fraser Scott P.,Becchetti AndreaORCID,Djamgoz Mustafa B. A.,Arcangeli AnnarosaORCID

Abstract

ABSTRACTThe cross talk between the Microenvironment (TME) and cancer cells controls proliferation, migration and pro-metastatic cancer behavior, often through integrin-mediated cell adhesion to the Extracellular Matrix (ECM). Integrin receptors coordinate signaling hubs constituted by multiprotein plasma membrane complexes often comprising ion channels and transporters. We here describe a novel signaling pathway triggered by (1 integrin activation by the ECM protein fibronectin (FN). This pathway involves a (1 integrin-centered plasma membrane complex formed by different transport proteins: the hERG1 K+channel, the neonatal form of the Na+channel NaV 1.5 (nNaV1.5) and the Na+/H+antiporter NHE1. The NHE1/hERG1/(1/nNaV1.5 complex is present on the plasma membrane of Breast Cancer (BCa) cells, in particular Triple Negative Breast Cancer (TNBCa). The expression of the two ion channels present in the complex is mutually regulated. The complex engagement by cell adhesion to FN stimulates a NHE1-mediated cytoplasmic alkalinization, which modulates f-actin organization. This in turn controls TNBCa migration and invasiveness. All this pathway is impaired by blocking either hERG1 or nNaV1.5 which also cause complex disassembly. The same result is obtained by harnessing the hERG1/(1 integrin complex through a single chain bispecific antibody (scDb-hERG1-(1).In conclusion, we uncovered a plasma membrane complex that recruits different ion transport proteins that regulate cellular K+, Na+and H+fluxes and cooperate in modulating downstream signals and thus malignant behavior. This complex could be targeted to develop novel therapeutic strategies for one of the most difficult-to-treat cancers, i.e. TNBCa.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3